Related Experiment Videos
[Effectiveness of protecting the myocardium against ischemia with a normothermic cardioplegic solution and creatine
Insights
Cardioplegic solutions with creatine phosphate (CP) show high efficacy in protecting rat hearts during normothermic cardiopulmonary bypass. Hypothermia significantly depressed functional recovery and energy phosphate levels, underscoring the benefits of normothermia.
Area of Science:
- Cardiovascular Surgery
- Biochemistry
- Physiology
Background:
- Cardiopulmonary bypass requires myocardial protection strategies.
- Creatine phosphate (CP) is investigated for its potential role in cardioplegic solutions (CS).
- Understanding the impact of temperature on CP efficacy is crucial.
Purpose of the Study:
- To evaluate the protective effects of CP-containing CS during ischemic cardiac arrest.
- To compare the efficacy of CP-containing CS under normothermic versus hypothermic conditions.
Main Methods:
- Isolated rat hearts underwent cardiopulmonary bypass and ischemic cardiac arrest.
- Coronary infusion with CP-containing CS was administered.
- Hearts were subjected to either normothermic (37°C) or hypothermic (4-6°C) regimes.
- Postischemic functional recovery and tissue high-energy phosphate levels (ATP, CP) were assessed.
Main Results:
- Normothermia group: 70-75% functional recovery; minimal reduction in ATP and CP.
- Hypothermia group: Markedly depressed functional recovery; significant decrease in high-energy phosphates.
- CP-containing CS demonstrated high efficacy under normothermia.
Conclusions:
- CP-containing cardioplegic solutions are highly effective in preserving cardiac function during normothermic cardiopulmonary bypass.
- Hypothermia diminishes the protective benefits of CP-containing cardioplegic solutions.
- Normothermic administration of CP-containing CS is recommended for optimal myocardial protection.
Abstract:
The protective effects of cardioplegic solutions (CS) containing creatine phosphate (CP) were studied in a rat heart model of cardiopulmonary bypass and ischemic cardiac arrest. Isolated rat hearts were subjected to a 3-minute coronary infusion with CS containing CP in normothermic (37 degrees C) and hypothermic (4-6 degrees C) regimes. In the normothermia group, the postischemic functional recovery was 70-75% of the preischemic control value, while the cellular ATP and CP content was reduced but insignificantly. By contrast, in the hypothermia group, the postischemic functional recovery was markedly depressed, with the tissue high-energy phosphate content being appreciably lowered. The data obtained confirm high efficacy of CP-containing cardioplegic solutions administered under normothermia conditions.